Immuneering Corp - Class A

Penny Stocks Biotech Stocks Healthcare Stocks

$4.60

+0.06 (+1.32%)

As of Jun 24, 10:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target -23.0% upside

Low Target $2.50

Average Target $3.54

High Target $3.55

Current Price $4.60

Current
$4.60

Target
$3.54

$2.50 $3.54 avg $3.55

Scenario Analysis

Bear Case

$2.50

-45.7%

Low target

Base Case

$3.54

-23.0%

Avg target

Bull Case

$3.55

+-22.8%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$10.08

-54.4% from high

52-Week Low

$2.06

+123.3% from low

Target vs 52W High

$3.54

-64.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%